Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer

R. S. Finn, D. H. Ahn, M. M. Javle, B. R. Tan, C. D. Weekes, J. C. Bendell, A. Patnaik, G. N. Khan, D. Laheru, R. Chavira, J. Christy-Bittel, E. Barrett, M. B. Sawyer, Tanios S. Bekaii-Saab

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences